Maravai LifeScience Holdings Inc. (MRVI) PT Lowered to $27 at Morgan Stanley
Tweet
Share
E-mailGet Alerts MRVI Hot Sheet
Price: $5.74 +1.06%
Rating Summary:
7 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Rating Summary:
7 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Join SI Premium – FREE
Morgan Stanley analyst Tejas Savant lowered the price target on Maravai LifeScience Holdings Inc. (NASDAQ: MRVI) to $27.00 (from $29.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Rockwell Medical Technologies (RMTI) PT Lowered to $20 at Maxim Group
- DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
